Episode Details

Cash flow isn’t just about having money—it’s about using it wisely. Some companies are sitting on piles but mismanaging investments, while others are turning cash into real value. CoStar Group’s earnings per share are slipping despite revenue growth, and its free cash flow margin is collapsing—red flags in a competitive market. Meanwhile, ANI Pharmaceuticals is exploding with 33%+ annual revenue growth and soaring free cash flow margins, giving it serious flexibility. TransUnion is also showing strong, sustained revenue growth with a healthy free cash flow margin, making it a solid bet for reinvestment or shareholder returns.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/caeb138c85b0df1a